News

NEW AD: Protect Our Care Launches Delaware Ad in Seven-Figure Campaign Calling for Action To Lower Drug Prices

By July 29, 2021No Comments

Delaware Patients Can’t Wait” Is Running on Digital Platforms Statewide

Watch the 30-Second Ad Here

Delaware — Protect Our Care launched a digital ad in Delaware as part of a seven-figure campaign about the skyrocketing cost of prescription drugs. The ad showcases the impact on patients when drug companies hike the price of essential medicines for Delawareans again and again. The ad makes clear the importance of giving Medicare the power to negotiate with drug companies for lower prices for all Americans. 

The ad is part of The Campaign to Reduce Drug Prices, a grassroots and communications campaign calling for comprehensive legislation to lower drug prices. The ad is running on digital platforms, focusing particularly on older Delawareans. Protect Our Care will continue to run ads and host events both nationally and in 14 key states, including Delaware, throughout the summer.

“It is shameful that Americans pay three times more for medicines than people in other countries,” said Protect Our Care Executive Director Brad Woodhouse. “While drug company profits soar, they continue to hike the price of lifesaving drugs for Delawareans and people across the country, forcing millions of families to choose between paying for the medicines they need to live or paying for food or rent. It’s time for Delaware lawmakers to do the right thing and support giving Medicare the power to negotiate for lower drug prices. The time to act is now.”

Script for “Delaware Patients Can’t Wait” (:30s):

It’s always the same thing. 

The costs of prescription drugs keep going up. 

How are patients supposed to afford this?

Families need these life-saving drugs just to stay alive.

Delaware families pay 3 times more than people do in other countries to get the same medicines. 

Drug companies make more and more profits, and drug prices go up and up for patients. 

We can’t wait any longer to act.

Congress needs to give Medicare the power to negotiate lower drug prices.